SlideShare a Scribd company logo
Soumettre la recherche
Mettre en ligne
Antibiotics Pediatric dosing.pdf
Signaler
Partager
Rahul Verma
Paediatric Registrar à Choithram Hospital & Research Centre, Indore (M.P.)
Suivre
•
0 j'aime
•
14 vues
1
sur
1
Antibiotics Pediatric dosing.pdf
•
0 j'aime
•
14 vues
Signaler
Partager
Télécharger maintenant
Télécharger pour lire hors ligne
Santé & Médecine
Antibiotics dosing in pediatrics
Lire la suite
Rahul Verma
Paediatric Registrar à Choithram Hospital & Research Centre, Indore (M.P.)
Suivre
Recommandé
Gastric carcinoma treatment par
Gastric carcinoma treatment
Preethiya Seenivasan
86 vues
•
28 diapositives
antibiotics induced renal failure par
antibiotics induced renal failure
Manoj Choudhary
2K vues
•
39 diapositives
PediRefCard.pdf par
PediRefCard.pdf
MuhammadAbbasWali
137 vues
•
2 diapositives
management of SLE.pptx par
management of SLE.pptx
Shah Prakashman
7 vues
•
41 diapositives
Leukemia case answer par
Leukemia case answer
ABDULLAHALHAJI2
341 vues
•
46 diapositives
Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric) par
Presentasi Kasus Bidang Geriatri (Pharmaceutical Geriatric)
Gilang Rizki
91 vues
•
17 diapositives
Contenu connexe
Similaire à Antibiotics Pediatric dosing.pdf
Arrhythmias par
Arrhythmias
Raniya Khalid
15 vues
•
11 diapositives
Anti platelet therapy par
Anti platelet therapy
BALASUBRAMANIAM IYER
4.9K vues
•
44 diapositives
263_Dosing-information-in-renal-impairment.pdf par
263_Dosing-information-in-renal-impairment.pdf
TAWFIKABBAD
1 vue
•
18 diapositives
Rheumatoid arthritis management par
Rheumatoid arthritis management
Praveen Nagula
7.1K vues
•
83 diapositives
DIRECT THROMBIN INHIBITORS.pptx par
DIRECT THROMBIN INHIBITORS.pptx
NOM KUMAR NAIK BHUKYA
21 vues
•
33 diapositives
DIAGNOSIS AND MANAGEMENT OF MALARIA par
DIAGNOSIS AND MANAGEMENT OF MALARIA
Nisheeth Patel
25.1K vues
•
46 diapositives
Similaire à Antibiotics Pediatric dosing.pdf
(20)
Arrhythmias par Raniya Khalid
Arrhythmias
Raniya Khalid
•
15 vues
Anti platelet therapy par BALASUBRAMANIAM IYER
Anti platelet therapy
BALASUBRAMANIAM IYER
•
4.9K vues
263_Dosing-information-in-renal-impairment.pdf par TAWFIKABBAD
263_Dosing-information-in-renal-impairment.pdf
TAWFIKABBAD
•
1 vue
Rheumatoid arthritis management par Praveen Nagula
Rheumatoid arthritis management
Praveen Nagula
•
7.1K vues
DIRECT THROMBIN INHIBITORS.pptx par NOM KUMAR NAIK BHUKYA
DIRECT THROMBIN INHIBITORS.pptx
NOM KUMAR NAIK BHUKYA
•
21 vues
DIAGNOSIS AND MANAGEMENT OF MALARIA par Nisheeth Patel
DIAGNOSIS AND MANAGEMENT OF MALARIA
Nisheeth Patel
•
25.1K vues
Ped medhandbook par Elhadi Hajow
Ped medhandbook
Elhadi Hajow
•
3.3K vues
Ped medhandbook par Elhadi Hajow
Ped medhandbook
Elhadi Hajow
•
2.8K vues
Anthracyclines par Dr. Chinmayee Agrawal
Anthracyclines
Dr. Chinmayee Agrawal
•
343 vues
Immune Thrombocytopenia Purpura par spa718
Immune Thrombocytopenia Purpura
spa718
•
1.7K vues
Antibiotics par Khurram Wazir
Antibiotics
Khurram Wazir
•
368 vues
Intravenous Drug Preparation and Administration EMTS Johore (1).pdf par azhaabaz
Intravenous Drug Preparation and Administration EMTS Johore (1).pdf
azhaabaz
•
267 vues
Nephrotic syndrome IN CHILDREN Lecture for MBBS par Sajjad Sabir
Nephrotic syndrome IN CHILDREN Lecture for MBBS
Sajjad Sabir
•
8.1K vues
Anti -Malarials - perspective and Treatment regimen par Muthuselvan Kamaraj
Anti -Malarials - perspective and Treatment regimen
Muthuselvan Kamaraj
•
542 vues
Cyclosporine by Aseem par Dr. Aseem Sharma
Cyclosporine by Aseem
Dr. Aseem Sharma
•
3.8K vues
Anti Emetics.pdf par Gamingbeast4848
Anti Emetics.pdf
Gamingbeast4848
•
12 vues
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antib... par PVI, PeerView Institute for Medical Education
Real-World, Real Innovation in DLBCL: Perspectives on Integrating Novel Antib...
PVI, PeerView Institute for Medical Education
•
41 vues
Metoclopramide hydrochloride 10 mg tablets smpc taj pharmaceuticals par Taj Pharma
Metoclopramide hydrochloride 10 mg tablets smpc taj pharmaceuticals
Taj Pharma
•
251 vues
Febuxostat for treatment of chronic gout par Choying Chen
Febuxostat for treatment of chronic gout
Choying Chen
•
5.4K vues
mTOR inhibitor in cancer par seayat1103
mTOR inhibitor in cancer
seayat1103
•
5.9K vues
Dernier
MENSTRUAL CYCLE.pdf par
MENSTRUAL CYCLE.pdf
Rutvikunvar Raualji (PT)
18 vues
•
24 diapositives
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx par
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx
JubinNath2
9 vues
•
12 diapositives
Small Intestine.pptx par
Small Intestine.pptx
Mathew Joseph
230 vues
•
50 diapositives
OVARIES.pdf par
OVARIES.pdf
Rutvikunvar Raualji (PT)
14 vues
•
15 diapositives
Examining Pleural Fluid.pptx par
Examining Pleural Fluid.pptx
Fareeha Riaz
21 vues
•
18 diapositives
Case Study_ AI in the Life Sciences Industry.pptx par
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP
36 vues
•
17 diapositives
Dernier
(20)
MENSTRUAL CYCLE.pdf par Rutvikunvar Raualji (PT)
MENSTRUAL CYCLE.pdf
Rutvikunvar Raualji (PT)
•
18 vues
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx par JubinNath2
CMC(CHEMISTRY,MANUFACTURING AND CONTROL).pptx
JubinNath2
•
9 vues
Small Intestine.pptx par Mathew Joseph
Small Intestine.pptx
Mathew Joseph
•
230 vues
OVARIES.pdf par Rutvikunvar Raualji (PT)
OVARIES.pdf
Rutvikunvar Raualji (PT)
•
14 vues
Examining Pleural Fluid.pptx par Fareeha Riaz
Examining Pleural Fluid.pptx
Fareeha Riaz
•
21 vues
Case Study_ AI in the Life Sciences Industry.pptx par Emily Kunka, MS, CCRP
Case Study_ AI in the Life Sciences Industry.pptx
Emily Kunka, MS, CCRP
•
36 vues
Thrives Priority Areas: Behavioral Health par City of Chesapeake
Thrives Priority Areas: Behavioral Health
City of Chesapeake
•
79 vues
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha... par PVI, PeerView Institute for Medical Education
The A-Team Against Relapsed/Refractory Myeloma: Community Strategies for Enha...
PVI, PeerView Institute for Medical Education
•
13 vues
homedoctorbook-com-book- (1).pdf par fatimasahar769
homedoctorbook-com-book- (1).pdf
fatimasahar769
•
8 vues
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) par The Swiss Pharmacy
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
The Swiss Pharmacy
•
12 vues
Nidanarthakara Roga.pptx par Akshay Shetty
Nidanarthakara Roga.pptx
Akshay Shetty
•
47 vues
Looking For Exceptional Dental Care In Simi Valley We’ve Got The Answer par Dental Group of Simi Valley
Looking For Exceptional Dental Care In Simi Valley We’ve Got The Answer
Dental Group of Simi Valley
•
11 vues
TQM ASSIGMENT 3.pdf par د حاتم البيطار
TQM ASSIGMENT 3.pdf
د حاتم البيطار
•
12 vues
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx par ABG
INTRODUCTION TO PHARMACEUTICAL VALIDATION SCOPE and MERITS OF VALIDATION.pptx
ABG
•
115 vues
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl... par DipeshGamare
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
DipeshGamare
•
15 vues
Quit Smoking Revolution.pdf par Gio Ferrandino
Quit Smoking Revolution.pdf
Gio Ferrandino
•
21 vues
Depression PPT template par EmanMegahed6
Depression PPT template
EmanMegahed6
•
23 vues
The Art of naming drugs.pptx par DanaKarem1
The Art of naming drugs.pptx
DanaKarem1
•
16 vues
Biomedicine & Pharmacotherapy par Trustlife
Biomedicine & Pharmacotherapy
Trustlife
•
199 vues
Cholera Romy W. (3).pptx par rweth613
Cholera Romy W. (3).pptx
rweth613
•
65 vues
Antibiotics Pediatric dosing.pdf
1.
LPCHS Formulary Antimicrobials
The doses provided are general recommendations and do NOT include neonatal dosing, cystic fibrosis dosing, or renal dose adjustment. Please refer to the Housestaff Manual or Neofax for additional recommendations and indication- specific dosing. Maximum individual doses in parentheses. Renal dose adjustment parameters indicated by superscript: 1 Adjustment needed if CrCl < 70 mL/min 2 Adjustment needed if CrCl < 50 mL/min 3 Adjustment needed if CrCl < 30 mL/min All inpatient restricted antimicrobial use, including continuation of home medications, requires Pedi- atric Infectious Disease (ID) approval. Contact the Pediatric ID fellow on-call for approval. For additional assistance, consider ASP or ID consultation. (ID) = Requires ID approval for use: Colistin Linezolid Posaconazole Cidofovir Micafungin Tigecycline Daptomycin (PI) = Prolonged infusion may be considered (i.e., extended infusion, continuous infusion) (R) = Restricted indications (requires ID approval) (TDM) = Therapeutic drug monitoring recommended GENERAL INFORMATION ABBREVIATIONS THERAPEUTIC DRUG MONITORING DRUG DOSING INTERVAL TROUGH (mcg/mL) PEAK* (mcg/mL) Amikacin Q8h < 8 20—30 Q24h 30—55 Gentamicin or Tobramycin Q8h < 1 4—10 Q24h 15—25 Posaconazole Variable Prophylaxis >700 ng/mL Treatment >1250 ng/mL N/A Vancomycin Usual dosing 10—20 N/A Voriconazole Q12h 1—6 N/A *30min post end of 30 min infusion or 60 min post end of 60min infusion PARENTERAL (IV) ANTIBIOTICS DRUG DOSAGE Amikacin2 (TDM) 7.5 mg/kg/dose q8h (500 mg) 15—20 mg/kg/dose q24h (1.5 g) CF: 30 mg/kg/dose q24h Ampicillin3 50—100 mg/kg/dose q6h (2g) Ampicillin/ sulbactam3 50 mg/kg/dose q6h (2g) (dose based on ampicillin) Aztreonam3 30 mg/kg/dose q6h (2g) CF: 50 mg/kg/dose q6h (2g) Cefazolin3 16.5—50 mg/kg/dose q8h (2g) Cefepime2 (PI) 50 mg/kg/dose q8h (2g) Cefoxitin 40 mg/kg/dose q6-8h (2g) Ceftazidime2 (PI) 50 mg/kg/dose q8h (2g) Ceftriaxone 50—75 mg/kg/dose q24h (2g) Meningitis: 50 mg/kg/dose q12h (2g) Ciprofloxacin3 10—15 mg/kg/dose q8-12h (400mg) Clindamycin 10—13 mg/kg/dose q8h (900mg) Colistin (ID)1 1.7—2.5 mg/kg/dose q8-12h Daptomycin3 (ID) 6—12 mg/kg/dose q24h Doxycycline 2 mg/kg/dose q12h (100mg) Gentamicin2 (TDM) 2—2.5 mg/kg/dose q8h 5—7.5 mg/kg/dose q24h Synergy: 1—3 mg/kg/dose q8-24h Levofloxacin2 <5yr: 8—10 mg/kg/dose q12h >5yr: 10 mg/kg/dose q24h (750mg) Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg) >12 yr: 10 mg/kg/dose q12h (600mg) Meropenem2 (PI) 20 mg/kg/dose q8h (1g) Meningitis/CF: 40 mg/kg/dose q8h (2g) Metronida- zole3 10 mg/kg/dose q8h (750mg) Appendicitis: 30 mg/kg/dose q24h (1g, unless >80kg, then 1.5g) Nafcillin3 (PI) 33-50 mg/kg/dose q4-6h (2g) Penicillin G3 25,000—66,000 units/kg/dose q4-6h (4million units) Piperacillin/ tazobactam2 (PI) 80—100 mg/kg/dose q6-8h (4g) Tigecycline (ID) <40kg: 1.2 mg/kg/dose q12h(50mg) >40kg: Load 1.2 mg/kg/dose (100 mg), followed by 50 mg q12h Tobramycin2 2—2.5 mg/kg/dose q8h 5—7.5 mg/kg/dose q24h Trimethoprim/ sulfamethoxa- zole 3 (dose based on trimethoprim) Treatment: 3-6 mg/kg/dose q12h (160mg) Stenotrophomonas: 5 mg/kg/dose q8h (320mg) PCP: 5 mg/kg/dose q6-8h (320mg) Vancomycin3 (TDM) 15—20 mg/kg/dose q6-8h (per Pharmacy) ENTERAL (PO) ANTIBIOTICS Amoxicillin3 12.5—30 mg/kg/dose TID (1g) S. pneumoniae: 40—45 mg/kg/dose BID (2g) Amoxicillin/ clavulanate3 12.5—30 mg/kg/dose TID (875mg) S. pneumoniae: 40—45 mg/kg/dose BID (2g) (dose based on amoxicillin) Azithromycin Respiratory infection: 10 mg/kg once on day 1 (500mg), then 5 mg/ kg (250mg) q24h on days 2-5 Cefdinir3 7 –14 mg/kg/dose daily—BID (600mg/day) Cefixime1 (R) 8 mg/kg/dose once daily (400mg) Cefuroxime3 15 mg/kg/dose BID (500mg) Cephalexin3 12.5—50 mg/kg/dose TID-QID (1g) Ciprofloxacin3 10—15 mg/kg/dose BID (750mg) Clindamycin3 7—10 mg/kg/dose TID (600mg) Doxycycline 2 mg/kg/dose q12h (100mg) Levofloxacin2 <5yr: 8—10 mg/kg/dose q12h >5yr: 10 mg/kg/dose q24h (750mg) Linezolid (ID) <12yr: 10 mg/kg/dose q8h (600mg) >12yr:10 mg/kg/dose q12h (600mg) Metronidazole 10 mg/kg/dose q8h (750mg) Nitro- furantoin1 (Macrodantin ®) Treatment: 1.2—2.5 mg/kg/dose QID (100mg) Prophylaxis: 1—2 mg/kg/dose daily—BID (100mg) Penicillin3 12.5 mg/kg/dose QID (500mg) Rifampin 5-10 mg/kg/dose daily-BID (600mg) Trime- thoprim / sulfamethoxa- zole3 Treatment: 3-6 mg TMP compo- nent/kg/dose q12h (160mg) Prophylaxis: 2-5mg TMP compo- nent/kg/dose daily (160mg) ANTIFUNGALS Liposomal amphotericin IV: 3—5 mg/kg/dose q24h Caspofungin Treatment: IV: Load 70 mg/m2 once (70mg), then 50 mg/m2 daily (50mg) Prophylaxis: IV: 1 mg/kg/dose q24h (50mg) Micafungin (ID) Treatment: IV: 2—4 mg/kg/dose q24h (150mg) Prophylaxis: IV: 1.5 mg/kg/dose q24h (50mg) Fluconazole2 IV/PO: Loading dose 6—12 mg/kg/ dose once, followed by 3– 12 mg/kg/ dose daily (800mg) Posaconazole (ID) (TDM) Treatment (suspension): 5.5 mg/kg/ dose QID (200mg) Prophylaxis (suspension): 4 mg/kg/ dose TID (200mg) Treatment/Prophylaxis (tablet): 300mg BID X 1 day, then 300mg once daily Voriconazole (TDM) See age-specific HSM recommendation Treatment: IV/PO: 6—9 mg/kg/dose q12h x 2 doses, followed by 4—9 mg/ kg/dose q12h Prophylaxis: IV/PO: 7 mg/kg/dose BID (200mg) ANTIVIRALS Acyclovir2 >70kg: Use ideal body weight Treatment: IV: 10—15 mg/kg/dose q8h (800mg); PO:15—20 mg/kg/dose 3 -5x/day (800mg); hydration required Prophylaxis: IV: 5 mg/kg/dose or 250 mg/m2 q8h (300mg); PO: 10—15 mg/ kg/dose TID (300mg) Cidofovir (ID) 1—5 mg/kg/dose IV 1-3 x/week (hydration required; +/- probenecid) Ganciclovir1 Treatment: 5 mg/kg/dose IV q12h Prophylaxis: 5 mg/kg/dose IV q24h Oseltamivir3 (PO) Treatment: 3 mg/kg/dose BID (75 mg) Prophylaxis: 3 mg/kg/dose daily (75mg) Valacyclovir2 Treatment: 20 mg/kg/dose PO BID (1g) Prophylaxis: 250—500 mg PO BID Valgan- ciclovir1 Treatment: 12—20 mg/kg/dose IV q12h (900 mg) Prophylaxis: 10—15 mg/kg/dose IV daily (900mg)